NCT07243171: A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 126 planned
- Started
- 18 Nov 2025
- Primary completion
- 5 Jan 2027
- Arms
- oral ecnoglutide C1, oral ecnoglutide C2, oral ecnoglutide C3, oral ecnoglutide C4, oral ecnoglutide C5, oral ecnoglutide C6
- Results
- None posted
- 18 Nov 2025: Trial started
- 21 Nov 2025: Trial registered